Atlantis Eyecare

Huntington Beach, California 92647-8693

0 studies enrolling now · 17 studies all time

What they study most

Cataract, Diabetic Macular Edema, Diabetic Macular Edema (DME), Diabetic Retinopathy, Full-thickness Macular Holes (MH), Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Glaucoma, Open-Angle, Macular Edema, Neovascular Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Ocular Hypertension

Studies at this site

• A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56 — Running, not enrolling
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
• Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration — Running, not enrolling
• A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
• Anti-VEGF Treatment for Prevention of PDR/DME — Completed
• ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects — Stopped early
• Effects of Pneumatic Vitreolysis on Vitreomacular Traction — Completed
• Effects of Pneumatic Vitreolysis on Macular Hole — Completed
• A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema — Completed
• Phase 4 IOP Signals Associated With ILUVIEN® — Completed
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO — Stopped early
• Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting — Completed
• PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
• Post-Approval Study of the Tecnis® Toric IOL — Completed
• Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed